Appropriate Use Criteria for 18 F-Floretyrosine (FET) PET Imaging in Patients with Primary Brain Tumors
Journal of Nuclear Medicine · 12.11.2026 · jnumed.126.274081
DOI: 10.2967/jnumed.126.274081 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Nuclear Medicine, online erschienen am 12.11.2026. Verfasst von Derek R Johnson und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiology, Mayo Clinic, Rochester, Minnesota; johnson.derek1@mayo.edu. Die Arbeit nennt 77 Literaturangaben.
Abstract (Originalsprache)
Imaging plays a key role in the diagnosis and management of patients with brain tumors. Magnetic resonance imaging (MRI) is generally considered the gold standard imaging modality in brain tumor characterization, and patients undergo regular MRI from the time of diagnosis to death. Despite the
Autor:innen und Institutionen
- Department of Radiology, Mayo Clinic, Rochester, Minnesota; johnson.derek1@mayo.edu.
- Department of Nuclear Medicine, LMU University Hospital, LMU Medizin, Ludwig-Maximilians-Universität München, and the German Cancer Consortium, Munich, Germany.
- Department of Radiation Oncology, Mayo Clinic, Rochester, Minnesota.
- Department of Neurosurgery, University of California, San Francisco, San Francisco, California.
- Department of Radiology, Mass General Brigham, Harvard Medical School, Boston, Massachusetts.
- Department of Radiology, Weill Cornell Medicine, New York, New York.
Zitieren
APA
Johnson, D. R., Albert, N. L., Breen, W. G., Hervey-Jumper, S. L., Huang, R. Y., Ivanidze, J., Kim, M. M., McConathy, J. E., Oberheim Bush, N. A., Parney, I. F., Preusser, M., Stupp, R., Sulman, E. P., Veronesi, M. C., Villanueva-Meyer, J. E., & Hope, T. A. (2026). Appropriate Use Criteria for 18 F-Floretyrosine (FET) PET Imaging in Patients with Primary Brain Tumors. Journal of Nuclear Medicine, jnumed.126.274081. https://doi.org/10.2967/jnumed.126.274081
Vancouver
Johnson DR, Albert NL, Breen WG, Hervey-Jumper SL, Huang RY, Ivanidze J, et al. Appropriate Use Criteria for 18 F-Floretyrosine (FET) PET Imaging in Patients with Primary Brain Tumors. Journal of Nuclear Medicine. 2026:jnumed.126.274081. doi:10.2967/jnumed.126.274081
BibTeX
@article{Johnson2026,
author = {Johnson, Derek R and Albert, Nathalie L and Breen, William G and Hervey-Jumper, Shawn L and Huang, Raymond Y and Ivanidze, Jana and Kim, Michelle M and McConathy, Jonathan E and Oberheim Bush, Nancy Ann and Parney, Ian F and Preusser, Matthias and Stupp, Roger and Sulman, Erik P and Veronesi, Michael C and Villanueva-Meyer, Javier E and Hope, Thomas A},
title = {Appropriate Use Criteria for 18 F-Floretyrosine (FET) PET Imaging in Patients with Primary Brain Tumors},
journal = {Journal of Nuclear Medicine},
year = {2026},
pages = {jnumed.126.274081},
doi = {10.2967/jnumed.126.274081}
}
EUVIMED